Recent development of ischaemic heart disease in sex difference

Postgraduate Medical Journal

Volumn 83, Issue 978, 2007, Pages 240-243

  Shu, Wang ^a,b   Lei, Wang ^b   Peng, Song ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b Chinese Medical Association   (China)

Author keywords

[No Author keywords available]

Indexed keywords

SEX HORMONE;

ANEMIA; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; EXERCISE ELECTROCARDIOGRAPHY; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE WALL; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; REVASCULARIZATION; REVIEW; SEX DIFFERENCE;

ANEMIA; C-REACTIVE PROTEIN; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; GONADAL STEROID HORMONES; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MYOCARDIAL ISCHEMIA; RISK FACTORS; SEX FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34247605551     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2006.053140     Document Type: Review

References (36)

1. O'Meara JG, Kardia SL, Armon JJ, et al. Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study. Arch Intern Med 2004;164:1313-18.
2. Bell DM, Nappi J. Myocardial infarction in women: a critical appraisal of gender differences in outcomes. Pharmacotherapy 2000;20:1034-44.
3. Make Every Mother and Child Count. Available at www.cdc.gov/od/spotlight/ nwhw/whlth05.htm (accessed 23 Nov 2005).
4. American Heart Association. Heart disease and stroke statistics: 2004 update. http://americanheart.org/clownloadable/heart/107296976694 OHSStats2004Update.pdf (accessed 15 Jan, 2004).
5. Stangl V, Baumann G, Stangl K. Coronary atherogenic risk factors in women. Eur Heart J 2002;23:1738-52.
6. Crilly MA, Bundred PE. Gender inequalities in the management of angina pectoris: cross-sectional survey in primary care. Scott Med J 2005;50:154-8.
7. Centers for Disease Control and Prevention. www.cdc.gov/nccdphp/ burdenbook2004; index.htm (Accessed 30 Dec 2005).
8. Frazier CG, Shah SH, Armstrong PW, et al. Prevalence and management of hypertension in acute coronary syndrome patients varies by sex: observations from the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events postacute coronary syndromes (SYMPHONY) randomised clinical trials. Am Heart J 2005;150:1260-7.
9. Gretchen L, Gierach MPH, Johnson BD, et al. Hypertension, menopause, and coronary artery disease risk in the women's ischemia syndrome evaluation (WISE) study. J Am Coll Cardiol 2006;47(Suppl 1):S50-8.
10. Populations Collaboration. Smoking, body weight, and CHD mortality in diverse populations. Prev Med 004, 38:834-40.
11. Bonaa KH. An alternative hypothesis explaining the gender differences in risk of coronary heart disease. Tidsskr Nor Laegeforen, 200210, 122:1783-7.
12. Acarturk E, Cayli M, Akpinar O, et al. Relation between age and gender differences in plasma triglyceride concentrations and coronary artery disease in Southern Turkey. Clin Chim Acta 2004;339:123-8.
13. Hoff JA, Quinn L, Sevrukov A, et al. The prevalence of coronary artery calcium among diabetic individuals without known coronary artery disease. J Am Coll Cardiol 2003;41:1008-12.
14. Raggi P, Shaw LJ, Berman DS, et al. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol 2004;43:1663-9.
15. Juutilainen A, Lehto S, Ronnemaa T, et al. Type 2 diabetes as a "coronary heart disease equivalent": an 18-year prospective population-based study in Finnish subjects. Diabetes Care 2005;28:2901-7.
16. Wessel TR, Arant CB, Olson MB, et al. Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women. JAMA 2004;292:1179-87.
17. Marroquin OC, Kip KE, Kelley D, et al. The metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from WISE. Circulation 2004;1009:714-21.
18. Kaplan JR, Manuck SB, Anthony MS, et al. Premenopausal social status and hormone exposure predict postmenopausal atherosclerosis in female monkeys. Obstet Gynecol 2002;99:381-8.
19. Bairey Merz CN, Johnson BD, Sharaf BL, et al. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. J Am Coll Cardiol 2003;41:413-19.
20. Ng MK, Quinn CM, McCrohon JA, et al. Androgens up-regulate atherosclerosis-refated genes in macrophages from males but not females: molecular insights into gender differences in atherosclerosis. J Am Coll Cardiol 2003;42:1306-13.
21. Chambless LE, Heiss G, Shahar E, et al. Prediction of ischemic stroke risk in the Atherosclerosis Risk in Communities study. Am J Epidemiol 2004;160:259-69.
22. Shaw LJ, Lewis JF, Hlatky MA, et al. Women's Ischemic Syndrome Evaluation: current status and future research directions, report of the National Heart Lung Blood Institute (NHLBI) workshop, section 5: gender-related risk factors for ischemic heart disease, October 2-4, 2002. Circulation 2004;109:56e-8e.
23. Raggi P, Shaw LJ, Berman DS, et al. Gender-based differences in the prognostic value of coronary calcium. J Women Health 2004;13:273-88.
24. Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-65.
25. Tracy RP. Inflammation in cardiovascular disease: cart, horse or both - revisited. Arterioscler Thromb Vasc Biol 2002;22:1514-15.
26. Arant CB, Wessel TR, Olson MB, et al. National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation study. Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation study, J Am Coll Cardiol 2004;43:2009-14.
27. Johnson BD, Kelsey SF, Bairey Merz CN. Clinical risk assessment in women: chest discomfort. Report from the WISE study. In: Shaw U, Redberg RF, eds, Coronary disease in women:evidence-based diagnosis and treatment. Totowa, NJ:Humana Press, 2003:129-42.
28. AHRQ. Diagnosis and treatment of coronary heart disease in women: systematic reviews of evidence on selected topics. Summary, evidence report/technology sssessment: Number 81, AHRQ Publication No.03-E036.Rockville, MD:Agency for Healthcare Research and Quality, 2003. http://www.ahrq.gov/clinic/ epssums/chdwtopsum.htm (Accessed 23 Nov 2005).
29. Rautaharju PM, Ge S, Nelson JC, et al. Comparison of mortality risk for electrocardiographic abnormalities in men and women with and without coronary heart disease (from the Cardiovascular Health Study). Am J Cardiol 2006;97:309-15.
30. Gulati M, Pandey DK, Arnsdorf MF, et al. Exercise capacity and the risk of death in women. Circulation 2003;108:1554-9.
31. Shetler K, Marcus R, Froelicher VF, et al. Heart rate recovery: validation and methodologic issues. J Am Coll Cardiol 2001;38:1980-7.
32. Shaw LJ, Vasey C, Sawada S, et al. Impact of gender on risk stratification by exercise and dobutamine stress echocardiography: long-term mortality in 4,234 women and 6,898 men. Eur Heart J 2005;26:447- 56.
33. Mieres JH, Shaw LJ, Hendel RC, et al. American Society of Nuclear Cardiology: task force on women and coronary artery disease. J Nucl Cardiol 2003;10:95-101.
34. Shaw LJ, Iskandrian AE. Prognostic value of stress gated SPECT in patients with known or suspected coronary artery disease. J Nucl Cardiol 2004;11:171-85.
35. Kuettner A, Beck T, Drosch T, et al. Diagnostic accuracy of noninvasive coronary imaging using 16-detector slice spiral computed tomography with 188 ms temporal resolution. J Am Coll Cardiol 2005;45:123-7.
36. Shaw LJ, Vasey C, Sawada S, et al. Impact of gender on risk stratification by exercise and dobutamine stress echocardiography: long-term mortality in 4,234 women and 6,898 men. Eur Heart J 2005;26:447- 56.